These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11079140)

  • 1. Monoclonal antibodies as enhancers of the host's immunoresponse against the tumour.
    Mellstedt H
    Ann Oncol; 2000; 11 Suppl 3():191-4. PubMed ID: 11079140
    [No Abstract]   [Full Text] [Related]  

  • 2. CTLA-4 blockade: autoimmunity as treatment.
    Kapadia D; Fong L
    J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
    [No Abstract]   [Full Text] [Related]  

  • 3. [Monoclonal antibodies as antineoplastic antibodies].
    Hashimoto Y
    Nihon Rinsho; 1983; 41(4):821-4. PubMed ID: 6887550
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor-binding antibodies and tumor immunity.
    Carmi Y; Engleman EG
    Oncotarget; 2015 Nov; 6(34):35129-30. PubMed ID: 26457878
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoclonal antibodies in cancer treatment.
    Baldwin RW; Byers VS
    Lancet; 1986 Mar; 1(8481):603-5. PubMed ID: 2869313
    [No Abstract]   [Full Text] [Related]  

  • 6. [Monoclonal antibodies and cancer].
    López González JS; Selman Lama M
    Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnosis and treatment of cancer using immuno-antibodies and application of monoclonal tumor antibodies].
    Koji T
    Rinsho Hoshasen; 1982 Sep; 27(9):879-85. PubMed ID: 6759722
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
    Schlom J; Weeks MO
    Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
    [No Abstract]   [Full Text] [Related]  

  • 9. Blocking monoclonal antibodies of TIM proteins as orchestrators of anti-tumor immune response.
    Baghdadi M; Takeuchi S; Wada H; Seino K
    MAbs; 2014; 6(5):1124-32. PubMed ID: 25517298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor Antibodies Can Drive Therapeutic T Cell Responses.
    Wittrup KD
    Trends Cancer; 2017 Sep; 3(9):615-620. PubMed ID: 28867165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An introduction to tumour immunology.
    James K
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-ErbB-2 monoclonal antibodies and ErbB-2-directed vaccines.
    Yip YL; Ward RL
    Cancer Immunol Immunother; 2002 Jan; 50(11):569-87. PubMed ID: 11807621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering mouse monoclonal antibodies for cancer immunotherapy.
    Orlandi R
    Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant chimeric monoclonal antibodies.
    Morrison SL; Schlom J
    Important Adv Oncol; 1990; ():3-18. PubMed ID: 2182522
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of tumor antigens with monoclonal antibodies: immunopathology and immunodiagnosis.
    Neville AM
    Curr Opin Immunol; 1991 Oct; 3(5):674-8. PubMed ID: 1684511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody therapy for cancer.
    Lovett DR; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1991; 12():147-63. PubMed ID: 1931442
    [No Abstract]   [Full Text] [Related]  

  • 17. Basic principles and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation award lecture.
    Schlom J
    Cancer Res; 1986 Jul; 46(7):3225-38. PubMed ID: 3518915
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypothesis: macrophages as effector cells for human tumor destruction mediated by monoclonal antibody.
    Steplewski Z; Herlyn D; Maul G; Koprowski H
    Hybridoma; 1983; 2(1):1-5. PubMed ID: 6678794
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.
    Ribas A; Camacho LH; Lopez-Berestein G; Pavlov D; Bulanhagui CA; Millham R; Comin-Anduix B; Reuben JM; Seja E; Parker CA; Sharma A; Glaspy JA; Gomez-Navarro J
    J Clin Oncol; 2005 Dec; 23(35):8968-77. PubMed ID: 16204013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibody therapy: a literature review].
    Del Debbio CB; Tonon LM; Secoli SR
    Rev Gaucha Enferm; 2007 Mar; 28(1):133-42. PubMed ID: 17658067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.